Metabolism of [3H]noradrenaline by the isolated rat uterus

1981 ◽  
Vol 59 (12) ◽  
pp. 1245-1249 ◽  
Author(s):  
Julio Fernández-Pardal ◽  
Martha F. Gimeno ◽  
Alvaro L. Gimeno

The metabolism of [3H]noradrenaline by uterine horns from estrous, ovariectomized, and ovariectomized and estrogen-treated rats was explored. Uterine strips are able to take up [3H]noradrenaline and store it for up to 85 min after the isotope incubation. The major compounds retained in the tissue from rats either ovariectomized or during estrus were [3H]noradrenaline and 3H-labelled O-methylated deaminate metabolites. The [3H]3,4-dihydroxyphenylglycol ([3H]DOPEG) and 3,4-dihydroxymandelic acid ([3H]DOMA) fractions were higher in tissues from ovariectomized rats than during estrus. Ovariectomy also increased significantly the spontaneous efflux of [3H]DOPEG and [3H]DOMA. The metabolic pattern of [3H]noradrenaline both in the tissue and in the efflux from ovariectomized rats was changed by estrogen treatment and became similar to those obtained during estrus. These data suggest a possible modulation of the noradrenaline metabolism by estrogens on the isolated rat uterus.

1979 ◽  
Vol 26 (2) ◽  
pp. 197-205 ◽  
Author(s):  
KEN'ICHI YAMAGUCHI ◽  
TAKAO AKAISHI ◽  
HIDEO NEGORO

1986 ◽  
Vol 40 ◽  
pp. 75
Author(s):  
Yoshiko Masubuchi ◽  
Taiichiro Ohno ◽  
Toshio Kumai ◽  
Masami Tanaka ◽  
Mitsuko Suetsuna ◽  
...  

Blood ◽  
1996 ◽  
Vol 87 (7) ◽  
pp. 2683-2692 ◽  
Author(s):  
NK Shevde ◽  
JW Pike

Loss of ovarian function leads to a significant increase in the number of bone-resorbing osteoclasts. Estrogen replacement is known to manifest bone protective effects in the treatment of postmenopausal osteoporosis. In the present study, we used ovariectomized rats to examine the effects of estrogen loss at the osteoclast progenitor colony forming unit-granulocyte macrophage (CFU-GM) level. A significant increase in CFU-GM number was observed as early as 7 days following ovariectomy, and correlated directly with an increase in the number of osteoclast-like cells generated in marrow cultures. The increase in CFU-GM following ovariectomy was abrogated in animals that received estrogen treatment in vivo. A similar suppressive effect was observed on CFU-GM number when ovariectomized rat marrow was treated with estrogen in vitro. This effect was blocked in the presence of the estrogen antihormone ICI 164,384. Thus, the data suggest the possibility that estrogen exerts a direct effect on osteoclast progenitors, and does so through the estrogen receptor-mediated mechanism. Ovariectomy also led to an increase in the early hematopoietic stem/progenitor cell population (Thy 1.1+ cells) as determined by FLOW cytometry methods. Morphological changes as well as terminal deoxynucleotidyl transferase assays revealed that estrogen treatment negated growth factor-induced proliferation of these early progenitors by promoting apoptosis. The cellular effects of estrogen in vitro together with the immunocytochemical detection of the estrogen receptor in these cells, strongly support the contention that in addition to osteoclast progenitors such as CFU-GM, earlier hematopoietic progenitors are also unique cellular targets for estrogen action.


1984 ◽  
Vol 36 ◽  
pp. 347
Author(s):  
Takashi Kano ◽  
Kenji Ishii ◽  
Yoshiko Kurobe ◽  
Joichi Ando
Keyword(s):  

Endocrinology ◽  
1988 ◽  
Vol 123 (2) ◽  
pp. 681-686 ◽  
Author(s):  
T. J. WRONSKI ◽  
M. CINTRON ◽  
A. L. DOHERTY ◽  
L. M. DANN

Toxicon ◽  
1995 ◽  
Vol 33 (3) ◽  
pp. 355-361 ◽  
Author(s):  
M. Mendonça ◽  
M.M.Profeta Da luz ◽  
L. Freire-Maia ◽  
J.R. Cunha-melo

Sign in / Sign up

Export Citation Format

Share Document